Improved prognosis following peritonectomy procedures and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from appendiceal carcinoma
P. Piso et al., Improved prognosis following peritonectomy procedures and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from appendiceal carcinoma, EUR J SUR O, 27(3), 2001, pp. 286-290
Aims: The prognosis of patients with peritoneal carcinomatosis from gastroi
ntestinal malignancies is poor. The aim of this study was to analyse the re
sults of multimodality treatment for peritoneal carcinomatosis of appendice
al carcinoma.
Patients and methods: From 07/95 to 01/00, 17 patients (13 males, 4 female,
median age 58 years) underwent peritonectomy procedures in combination wit
h intraperitoneal hyperthermic chemotherapy. Surgical, pathological and sur
vival data were analysed retrospectively.
Results: All patients had undergone previous surgical treatment and one pat
ient had received chemotherapy. In all patients peritonectomy procedures, a
s described by Sugarbaker, were performed with the aim of achieving a macro
scopically complete cytoreduction (range 2-6, median 4 procedures per patie
nt). Following resection, open hyperthermic intraperitoneal chemotherapy wi
th cisplatin was performed. Eleven patients had postoperative complications
(predominantly "non-surgical") and two patients died postoperatively. The
4-year survival rate was 75%. Complete cytoreducion had a statistically sig
nificant positive influence on long-term survival.
Conclusions: In selected patients (WHO status 0/1, minimal residual disease
, no distant metastases, complete cytoreduction), the prognosis for patient
s with peritoneal carcinomatosis of appendiceal origin can be improved by p
eritonectomy procedures and hyperthermic intraperitoneal chemotherapy. Post
operative morbidity may be increased due to "non-surgical" complications. (
C) 2001 Harcourt Publishers Ltd.